Diagnosi, protesi, vaccini, genomica: la medicina che guadagna anni di vita.
La medicina che guadagna anni di vita: screening assistiti dall’IA che esaminano milioni di pazienti, vaccini di nuova generazione, una genomica che passa dal sequenziamento alla terapia, protesi e impianti che restituiscono capacità perdute. La rubrica segue le sperimentazioni cliniche concluse, le autorizzazioni all’immissione in commercio, le adozioni ospedaliere — il momento in cui una tecnologia smette di essere una pubblicazione per diventare una cura.
I numeri comandano: coorti, tassi di rilevamento, mortalità evitata, costi. Copriamo volentieri i sistemi sanitari che adottano su larga scala — l’India, il Brasile, il Sud-est asiatico — perché le tecnologie frugali si mettono spesso alla prova lì prima di arrivare altrove. Ogni articolo si appoggia alla sperimentazione, all’autorizzazione o allo studio che lo fonda, e li cita.
The TPMS design was developed by Bettina Wiegmann’s team at Hannover Medical School with RWTH Aachen researchers.
The figure came from women who received the program as intended, versus 49.9% with usual care.
Imaging reveals a right-twisting inner layer inside a left-twisting outer layer.
A 205-patient cohort found lower serum urea, phosphate and potassium with protein prescriptions of ≤0.6 g/kg/day.
More than 3,300 adults were analyzed across Ghana, Nigeria, Kenya and Europe.
The test uses an extra four microliters of blood and returns a result in 10–20 minutes.
A citrus flavonoid shifted old mice’s liver activity toward a younger profile.
WashU researchers found lymph node-like structures in the skull marrow of mice and evidence of similar cells in humans.
Indigo light is abundant in sunlight but scarce in standard white LED lighting.
IOCAS researchers linked an oyster energy-stress pathway to glycolysis in human lung adenocarcinoma cells.
The 9D5 antibody protected mice from lethal CCHFV infection and recognized a protein shared across several virus strains.
The pattern appeared in three datasets covering 2,616 colorectal tumors.
GT19630 targets MYC and GSPT1 together in leukemia, lymphoma and multiple myeloma models.
The study involved 22 people in brain imaging and 20 in magnetic stimulation experiments.
A randomized pilot tested daily 20 mg of zinc in 100 Ugandan children aged 1 to 5.
Teams in Australia and Hong Kong tracked nutrients from cell organelles into newly formed bone.
University of Michigan researchers combined BET and DNMT inhibitors against prostate tumors that had changed cellular identity.
The case involved one patient whose treatment-resistant lung tumor disappeared after a treatment protocol involving selenite and chemotherapy.